There’s a reason NiaHealth didn’t launch with fanfare and fog machines. They were too busy building what most of the Canadian healthcare system still hasn’t figured out, how to actually prevent illness, not just react to it. That’s not disruption, that’s long-overdue logic. And today, the market just gave them $5.75M more reasons to double down.
Led by Matt Golden and the team at Golden Ventures, with heavyweights like Kyle Braatz (Fullscript), Satish Kanwar and Arati Sharma (Good Future), Jonathan Ehrlich (Roar Ventures), Zach Coelius (Coelius Capital), The51, Jason Smith (Klue), Kathy Butler (CIBC), and returning fire from Boris Wertz (Version One Ventures), ScaleGood Fund, Garage Capital, and Ivan Yuen (Wattpad), this seed round just poured jet fuel on a rocket that’s already breaking orbit.
NiaHealth is what happens when a Sensassure founder (Sameer Dhar), a policy-obsessed healthcare operator (Mike Goss), a deep-stack tech architect (Saif Uddin Mahmud), and a clinical veteran who’s actually seen the gaps up close (Tanya ter Keurs, NP) decide Canada deserves more than “just wait and see what the ER says.” They’re making biomarker testing, CGMs, AI-driven healthspan dashboards, and clinician reviews the starting point, not the emergency backup plan.
You can’t buy longevity, but you can build toward it. And with over 100,000 biomarker tests run during stealth, 12,000+ Canadians still waiting in line, and usage growing at 30% MoM, it’s clear the demand isn’t coming, it’s already here. Add in partnerships with the University of Alberta and Ada, and NiaHealth isn’t just collecting data, they’re creating infrastructure. Quietly. Nationwide. Nine provinces and counting. Québec, you’re on deck.
This round fuels their Platform 2.0 rollout, think expanded biomarker panels, CGM data in real-time, and AI that doesn’t just flag risk, but starts building the playbook to avoid it altogether. They’re also leaning hard into employer partnerships, scaling the clinical and data science team, and yes, finally giving Canada’s six million primary-care-orphaned citizens a reason to believe in proactive medicine.
Here’s the twist: nothing about this is theoretical. This isn’t “the future of health.” It’s the now. And NiaHealth’s move is less about fixing a broken system and more about quietly building the one that should’ve existed all along.
So congrats to Co-Founder and CEO Sameer Dhar, Co-Founder and Clinical Director Tanya ter Keurs, Co-Founder and COO Mike Goss, and Co-Founder and CTO Saif Uddin Mahmud. You didn’t just raise a round. You raised expectations. And the bar’s never looking back.
